drug
antihemophilic factor (recombinant), plasma/albumin free method
Marketedupdated 3mo agoby Baxalta Inc
Approvedcommunity read0 votes
all catalysts(0)
nothing on the calendar yet
Trials studying antihemophilic factor (recombinant), plasma/albumin free method
- phase3A Study of Recombinant Von Willebrand Factor (rVWF) in Chinese Participants With Von Willebrand Disease (vWD)
- phase3A Study of Vonicog Alfa (rVWF) in Children With Severe Von Willebrand Disease (vWD)
- —ADVATE/ ADYNOVI Hemophilia A Outcome Database (AHEAD)
- phase4A Study of ADVATE in People With Hemophilia A in India
- phase1A Study to Evaluate the Pharmacokinetics，Safety and Tolerability of PEG Recombinant Human Coagulation Factor VIII-Fc Fusion Protein for Injection
- phase1A Study to Evaluate the Safety and Pharmacokinetic of Recombinant Human Coagulation Factor VIII ，Fc Fusion Protein for Injection
News(0)
no news has mentioned this drug yet
Data sources
last refreshed 21m ago
Found something off?
comments(0)
5-min edit window · permanent after that